identification candidate therapeutic autophagy-inducing peptide 
lysosomal degradation pathway autophagy crucial role defence infection neurodegenerative disorders cancer ageing accordingly agents induce autophagy may broad therapeutic applications one approach developing agents exploit autophagy manipulation strategies used microbial virulence factors show peptide tat-beclin -derived region autophagy protein beclin binds human immunodeficiency virus hiv- nef-is potent inducer autophagy interacts newly identified negative regulator autophagy gapr- also called glipr2 tat-beclin decreases accumulation polyglutamine expansion protein aggregates replication several pathogens including hiv- vitro reduces mortality mice infected chikungunya west nile virus thus characterization domain beclin interacts hiv- nef developed autophagy-inducing peptide potential efficacy treatment human diseases 
